Effective inhibition of metastasis in triple-negative breast cancer (TNBC) mouse model by combining immunogenic chemotherapy and immune checkpoint blockade

被引：0
|
作者：
Yuan, Xiangliang [1 ]
Xiao, Yi [1 ]
Liu, Xianghua [1 ]
Kuo, Wenling [1 ]
Li, Hongzhong [1 ]
Li, Ping [1 ]
Yagita, Hideo [2 ]
Yu, Dihua [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Juntendo Univ, Sch Med, Tokyo, Japan
来源：
CANCER RESEARCH | 2018年 / 78卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2018-4565
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4565
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Study on mouse model of triple-negative breast cancer: association between higher parity and triple-negative breast cancer
    Chun Huang
    Xuan Wang
    Baocun Sun
    Man Li
    Xiulan Zhao
    Yanjun Gu
    Yanfen Cui
    Yan Li
    Targeted Oncology, 2015, 10 : 85 - 97
  • [42] Study on mouse model of triple-negative breast cancer: association between higher parity and triple-negative breast cancer
    Huang, Chun
    Wang, Xuan
    Sun, Baocun
    Li, Man
    Zhao, Xiulan
    Gu, Yanjun
    Cui, Yanfen
    Li, Yan
    TARGETED ONCOLOGY, 2015, 10 (01) : 85 - 97
  • [43] Subtyping of triple-negative breast cancer (TNBC): A cohort study
    Thomssen, Christoph
    Hartung, Caroline
    Porsch, Martin
    Stuckrath, Kathrin
    Buchmann, Jorg
    Kantelhardt, Eva J.
    Vetter, Martina
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [44] Triple-negative Breast Carcinoma (TNBC) Immunoncology also effective in Neoadjuvancy
    Freye, Reimund
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (05) : 247 - 247
  • [45] The Evolving Role of Immune Checkpoint Inhibitors in the Treatment of Triple-Negative Breast Cancer
    Steiner, Meghan
    Tan, Antoinette R.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (05) : 305 - 315
  • [46] Involvement of proinflammatory chemokines in triple-negative breast cancer (TNBC)
    Ignacio, Rosa Mistica C.
    Gibbs, Carla
    Lee, Eun-Sook
    Son, Deok-Soo
    CANCER RESEARCH, 2016, 76
  • [47] Updates on Targeted Therapy for Triple-Negative Breast Cancer (TNBC)
    Noor Z.S.
    Master A.
    Current Breast Cancer Reports, 2018, 10 (4) : 282 - 288
  • [48] Our experience with immune checkpoint inhibitors in triple-negative breast cancer patients
    Nishio, Minako
    Kojitani, Yoshiki
    Kitashiro, Saya
    Ishiduka, Yasunobu
    Otsuka, Tomoyuki
    Nishida, Naohiro
    Fujisawa, Fumie
    Sugimoto, Naotoshi
    Yagi, Toshinari
    Souma, Ai
    Kanaoka, Haruka
    Oyamayama, Yuri
    Taniguchi, Azusa
    Nakajima, Satomi
    Seto, Yukiko
    Kusama, Hiroki
    Watanabe, Noriyuki
    Matsui, Saki
    Nakayama, Takahiro
    Kudou, Toshihiro
    ANNALS OF ONCOLOGY, 2023, 34 : S1465 - S1465
  • [49] Information preferences of women with triple-negative breast cancer (TNBC).
    Swiger, Kathleen Dickerson
    Sendecki, Jocelyn A.
    Guglielmino, Janine E.
    Rugo, Hope S.
    Domchek, Susan M.
    Anders, Carey K.
    Stricker, Carrie Tompkins
    Nelson, Hillary C. M.
    Hanson, Arin Ahlum
    Dinerman, Hayley
    Henry, Catherine Creme
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [50] The emerging role of immune checkpoint inhibitors in the treatment of triple-negative breast cancer
    Singh, Sima
    Numan, Arshid
    Maddiboyina, Balaji
    Arora, Saahil
    Riadi, Yassine
    Md, Shadab
    Alhakamy, Nabil A.
    Kesharwani, Prashant
    DRUG DISCOVERY TODAY, 2021, 26 (07) : 1721 - 1727
12345